Generics - AstraZeneca, Markets & Marketing

Filter

Popular Filters

Amneal debuts generic Esomeprazole strontium in USA

07-01-2014

Privately-held US generics drugmaker Amneal Pharmaceuticals has announced the launch of generic esomeprazole…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsMarkets & MarketingNexiumNorth AmericaUSA

US Appeals Court puts temporary stop on sales of generics of AstraZeneca's Pulmicort Respules

27-05-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced last Friday (May 24) that the US Court of Appeals…

ActavisAstraZenecaGenericsLegalMarkets & MarketingNorth AmericaPharmaceuticalPulmicort RespulesRespiratory and Pulmonary

Impax launches authorized generic of Zomig, as Mylan debuts copy of Tricor in USA

20-05-2013

US drugmaker Impax Laboratories (Nasdaq: IPXL) says that its generics division, Global Pharmaceuticals,…

AbbVieAstraZenecaCardio-vascularGenericsImpax LaboratoriesMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaTricorZomig

Actavis wins generic Pulmicort Respules case; challenges AbbVie patent

02-04-2013

US generic drugs maker Actavis (NYSE: ACT) has confirmed that the US District Court for the District…

AbbVieActavisAndroGelAstraZenecaGenericsMarkets & MarketingMen's HealthNorth AmericaPatentsPulmicort RespulesRegulationRespiratory and Pulmonary

Wockhardt generic versions of Pfizer's Geodon and AstraZeneca's Plendil OKed by FDA

23-08-2012

Wockhardt generic versions of Pfizer's Geodon and AstraZeneca's Plendil OKed by FDA

AstraZenecaCardio-vascularGenericsGeodonMarkets & MarketingNeurologicalNorth AmericaPfizerPlendilRegulationWockhardt

Watson debuts generic Nexium in Europe; Mylan launches Amidate copy in USA

08-08-2012

US generics firm Watson Pharmaceuticals (NYSE: WPI) said yesterday that its third-party business Specifar…

AmidateAstraZenecaEuropeGastro-intestinalsGenericsHospiraMarkets & MarketingMylan LaboratoriesNeurologicalNexiumNorth AmericaRegulationWatson Pharmaceuticals

Slow-down of European bipolar therapy market set for short-term slowdown

04-07-2012

Patent expiry of key blockbuster atypical antipsychotic drugs is likely to cause a decline in growth…

AstraZenecaEuropeGenericsMarkets & MarketingNeurologicalPatentsPharmaceuticalPricingSeroquel

Actavis reportedly to be acquired by Watson; debuts generic Zomig

22-03-2012

Icelandic generic drugmaker Actavis is said to be in talks to be acquired by US peer Watson Pharmaceuticals…

ActavisAstraZenecaEuropeGenericsMarkets & MarketingMergers & AcquisitionsNeurologicalPatentsWatson PharmaceuticalsZolmitriptanZomig

AstraZeneca in two more Seroquel XR patent settlements; Actavis outlines South America aims

06-10-2011

In further patent settlements in the USA, Anglo-Swedish drug major AstraZeneca (LSE: AZN) has now announced…

Accord HealthcareActavisAstraZenecaGenericsIntas PharmaceuticalsLegalMarkets & MarketingNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XRSouth America

Ranbaxy debuts first approved generic of Nexium in the UK

05-09-2011

The UK subsidiary of India largest drugmaker Ranbaxy (RANB: BO) says that it has successfully launched…

AstraZenecaEuropeGastro-intestinalsGenericsMarkets & MarketingNexiumRanbaxy Laboratories

Back to top